The state has provided the latest drugs under the presidential women's health initiative.. and approves the "smart drug" with high efficacy against aggressive tumors
Youm7:
Dr. Mohsen Mokhtar, Professor of Clinical Oncology at Kasr Al Ainy Faculty of Medicine, revealed that a breakthrough has occurred in breast cancer treatment because of the presidential women's health initiatives, thanks to early detection and the modern treatments provided free of charge to women with breast cancer. He explained, during a press conference today on the new effective drugs launched in Egypt and the role of the presidential initiative in supporting women's health and detecting breast cancer cases early, that what is called the smart chemotherapy drug for treating breast cancer has been launched; it is a targeted chemotherapy that does not harm healthy cells and achieves a high response in breast cancer treatment.
He added that conventional chemotherapies targeted the tumor and the neighboring healthy cells, but now the smart drug affects only cancer cells and represents a breakthrough in treatment, explaining that 75% of women with breast cancer benefit from this drug, and that it will be available to Egyptian women after being approved by the US Food and Drug Administration "FDA" and also by the Egyptian Drug Authority, noting that it will be included at the state's expense after negotiations are held to reduce its price, so that it is available free of charge to women with breast cancer.
He said that a large proportion of women may benefit from it, and if the patient has HER2 receptors it achieves great efficacy, explaining that it achieves about 60% response; it is taken in the late stages of breast cancer and will later be tested in the early stages. He pointed out that the presidential initiative provides effective treatments and improves tumor cure outcomes, and is an incentive for women because detection is early, and it does not cause complications for women's health.
He added that the presidential initiatives have made a great effort in providing treatments free of charge, and today the treatment protocols available in Egypt match those in European countries. For his part, Dr. Hamdy Abdel Azim, Professor of Clinical Oncology at Kasr Al Ainy Faculty of Medicine and former Head of the National Committee for Women's Health, said that the women's health initiative has been activated since 2019, explaining that diagnosing breast cancer in its early stages improves breast cancer cure rates, and that a report on the initiative was presented in 2022 to President El-Sisi; during this period we were able to raise early diagnosis rates from 30% to 60%, an unprecedented figure in any country, explaining that the presidential women's health initiative succeeded in providing modern treatments free of charge to affected women, and noting that the new drugs have achieved a breakthrough in treatment. He said that through the presidential women's health initiative, from 2019 to 2022, during the first 3 and a half years, we discovered about 6,000 breast cancer cases out of 12 million cases through screening, explaining that most of the new drugs have been included in the state-funded treatment system.
Dr. Hamdy Abdel Azim said that the state was responsible for women's health in Egypt, noting that cancerous breast tumors spread in the breast tissue, but the difference between them lies in their aggressiveness and whether or not they spread.